Regeneron
Trade Regeneron 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About REGN
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara.
REGN Key Statistics
Stock Snapshot
The current Regeneron(REGN) stock price is $664.45, with a market capitalization of 69.66B. The stock trades at a price-to-earnings (P/E) ratio of 15.99 and offers a dividend yield of 0.55%.
On 2026-07-15, Regeneron(REGN) stock moved within a range of $648.66 to $669.10. With shares now at $664.45, the stock is trading +2.4% above its intraday low and -0.7% below the session's peak.
Trading activity shows a volume of 555.39K, compared to an average daily volume of 751.64K.
Over the past 52 weeks, Regeneron(REGN) stock has traded between a high of $821.11 and a low of $541.00.
Over the past 52 weeks, Regeneron(REGN) stock has traded between a high of $821.11 and a low of $541.00.
REGN News
In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Regeneron Pharmaceuticals, Inc. (Symbol: REGN) has take...
Regeneron’s (REGN) dupilumab was granted FDA orphan drug designation, according to a post on the agency’s website. TipRanks has entered a new arena in the inve...
...
Analyst ratings
71%
of 31 ratingsMore REGN News
Regeneron Pharmaceuticals recently faced a setback after disappointing clinical trial results for one of its pipeline drugs, even as key products Dupixent and E...
Analyst Tazeen Ahmad from Bank of America Securities reiterated a Buy rating on Regeneron and decreased the price target to $856.00 from $860.00. TipRanks has...
Piper Sandler analyst Biren Amin lowered the firm’s price target on Regeneron (REGN) to $854 from $855 and keeps an Overweight rating on the shares. The firm up...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.